Shunji Hasegawa

Shunji Hasegawa

Auto-generated profile, based on publicly available information

Shunji Hasegawa

Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2011 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
SHS. Hasegawa
S. Hasegawa
TIT. Ichiyama
T. Ichiyama
ISI. Sonaka
I. Sonaka
AOA. Ohsaki
A. Ohsaki
SOS. Okada
S. Okada
SFS. Furukawa
S. Furukawa
Summary: The activation of nuclear factor-kappa B (NF-κB) in vascular endothelial cells may be involved in vascular pathogeneses such as vasculitis or atherosclerosis. Recently, it has been reported that some amino acids exhibit anti-inflammatory effects. We investigated the inhibitory effects of a panel of amino acids on cytokine production or expression of adhesion molecules that are involved in inflammatory diseases in various cell types. The activation of NF-κB was determined in human coronary arterial endothelial cells (HCAECs) because NF-κB modulates the production of many cytokines and the expression of adhesion molecules. We examined the inhibitory effects of the amino acids cysteine, histidine and glycine on the induction of NF-κB activation, expression of CD62E (E-selectin) and the production of interleukin (IL)-6 in HCAECs stimulated with tumour necrosis factor (TNF)-α. Cysteine, histidine and glycine significantly reduced NF-κB activation and inhibitor κBα (IκBα) degradation in HCAECs stimulated with TNF-α. Additionally, all the amino acids inhibited the expression of E-selectin and the production of IL-6 in HCAECs, and the effects of cysteine were the most significant. Our results show that glycine, histidine and cysteine can inhibit NF-κB activation, IκBα degradation, CD62E expression and IL-6 production in HCAECs, suggesting that these amino acids may exhibit anti-inflammatory effects during endothelial inflammation.

1 August 2015 in Brain and Development
Verified
Journal Article
Closed access
SHShunji Hasegawa
Shunji Hasegawa
TMTakeshi Matsushige
Takeshi Matsushige
MKMadoka Kajimoto
Madoka Kajimoto
HIHirofumi Inoue
Hirofumi Inoue
HMHiroshi Momonaka
Hiroshi Momonaka
JDJapanese Society For Pediatric Immune-Mediated Brain Diseases
Japanese Society For Pediatric Immune-Mediated Brain Diseases

29 September 2011 in Allergy
Verified
Journal Article
Closed access
PDF file
SHS. Hasegawa
S. Hasegawa
RHR. Hirano
R. Hirano
ROR. Okamoto-Nakagawa
R. Okamoto-Nakagawa
TIT. Ichiyama
T. Ichiyama
KSK. Shirabe
K. Shirabe

1 May 2011 in Cytokine
Verified
Journal Article
Closed access
SHShunji Hasegawa
Shunji Hasegawa
TMTakeshi Matsushige
Takeshi Matsushige
HIHirofumi Inoue
Hirofumi Inoue
KSKomei Shirabe
Komei Shirabe
RFReiji Fukano
Reiji Fukano
TITakashi Ichiyama
Takashi Ichiyama

1 July 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
TKTetsuhiro Kibata
Tetsuhiro Kibata
YSYasuo Suzuki
Yasuo Suzuki
SHShunji Hasegawa
Shunji Hasegawa
TMTakeshi Matsushige
Takeshi Matsushige
TKTakeshi Kusuda
Takeshi Kusuda
SOShouichi Ohga
Shouichi Ohga

23 February 2011 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
SHShunji Hasegawa
Shunji Hasegawa
RHReiji Hirano
Reiji Hirano
KHKunio Hashimoto
Kunio Hashimoto
YHYasuhiro Haneda
Yasuhiro Haneda
KSKomei Shirabe
Komei Shirabe
TITakashi Ichiyama
Takashi Ichiyama